Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 10.6 USD 15.59% Market Closed
Market Cap: 273.9m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 10.71 USD with a low forecast of 10.1 USD and a high forecast of 11.55 USD.

Lowest
Price Target
10.1 USD
5% Downside
Average
Price Target
10.71 USD
1% Upside
Highest
Price Target
11.55 USD
9% Upside

ETON Last Price Targets
Eton Pharmaceuticals Inc

The latest public price target was made on Oct 28, 2024 by Chase Knickerbocker from Craig-Hallum , who expects ETON stock to rise by 42% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Chase Knickerbocker
Craig-Hallum
15 USD
Upside 42%
2 weeks ago
Oct 28, 2024
Eton Pharmaceuticals (ETON) PT Raised to $15 at Craig-Hallum
StreetInsider
Swayampakula Ramakanth
H.C. Wainwright
11 USD
Upside 4%
1 month ago
Oct 4, 2024
Eton Pharmaceuticals price target raised to $11 from $9 at H.C. Wainwright
TheFly
Chase Knickerbocker
Craig-Hallum
8 USD
Downside 25%
6 months ago
May 6, 2024
Eton Pharmaceuticals initiated with a Buy at Craig-Hallum
TheFly
Chase Knickerbocker
Craig-Hallum
Price Target 15 USD
Upside/Downside 42%
View Source
Swayampakula Ramakanth
H.C. Wainwright
Price Target 11 USD
Upside/Downside 4%
View Source
Chase Knickerbocker
Craig-Hallum
Price Target 8 USD
Upside/Downside 25%
View Source
Eton Pharmaceuticals Inc Competitors:
Price Targets
NEULANDLAB
Neuland Laboratories Ltd
18% Downside
MEGA
Mega Lifesciences PCL
20% Upside
300725
PharmaBlock Sciences Nanjing Inc
6% Upside
BSEM
Biostem Technologies Inc
6% Upside

Revenue
Forecast

Revenue Estimate
Eton Pharmaceuticals Inc

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 44%.

N/A
Past Growth
44%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
10.71 USD

According to Wall Street analysts, the average 1-year price target for ETON is 10.71 USD with a low forecast of 10.1 USD and a high forecast of 11.55 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
44%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 44%.

Back to Top